VivoSeq
Other

Nitric Oxide

0

Pipeline Programs↗

4

Active Trials↗

1

Companies Involved↗

Nitric Oxide is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

81/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novartis logo

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

41

clinical trials

Completed29 · 71%
Terminated4 · 10%
Active, not recruiting3 · 7%
Withdrawn3 · 7%
Enrolling by invitation1 · 2%
Unknown status1 · 2%

Clinical Trials

Trial Activity

41 trials

Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
Active, not recruiting·—·N/A·NCT02115724·74 enrolled
Diffuse Optical Monitoring With Inhaled Nitric Oxide
Active, not recruiting·—·Phase 2·NCT03023449·40 enrolled
Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance
Active, not recruiting·ZZhongnan Hospital·N/A·NCT06660784·80 enrolled
Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge
Enrolling by invitation·IIndiana University·Phase 2·NCT04738422·150 enrolled
Nitric Oxide, GeNO Nitrosyl Delivery System
Completed·WWake Forest University Health Sciences·Phase 2·NCT01165047·10 enrolled
Reduction of Cesareans by Nitric Oxide (NO) Donors in Post Term Pregnancies
Completed·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT00930618·1,409 enrolled
Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)
Completed·RRegional Hospital Holstebro·Phase 2·NCT02078973·15 enrolled
Diesel Exhaust Inhalation, Systemic Nitric Oxide Inhibition and Cardiac Output
Completed·UUniversity of Edinburgh·N/A·NCT01060930·14 enrolled
Inhaled Nitric Oxide by Oxygen Hood in Neonates
Completed·UUniversity of Alabama at Birmingham·Phase 4·NCT00732537·8 enrolled
The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
Completed·MMallinckrodt·Phase 2·NCT00060840·150 enrolled
Role of Nitric Oxide in the Impact of Aging on Myocardial Remodeling
Completed·WWashington University School of Medicine·N/A·NCT00603720·54 enrolled
Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot
Completed·NNitric Solutions Inc.·Phase 2·NCT02871011·20 enrolled
Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
Completed·RRegional Hospital Holstebro·Phase 2·NCT01638663·20 enrolled
Nitric Oxide During Bypass for Arterial Switch Operation
Completed·MMurdoch Childrens Research Institute·Phase 3·NCT03661385·300 enrolled
RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study
Completed·UUniversity Hospital Southampton NHS Foundation Trust·Phase 2·NCT02295566·12 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)